TY - JOUR
T1 - Cohort profile
T2 - The Spanish Early-onset Colorectal Cancer (SECOC) cohort: A multicentre cohort study on the molecular basis of colorectal cancer among young individuals in Spain
AU - Perea, Jose
AU - Marti, Marc
AU - Espin, Eloy
AU - Hernandez-Villafranca, Sergio
AU - Orihuela, Pilar
AU - Vidal Tocino, Rosario
AU - Alcazar, Jose Antonio
AU - Vivas, Alfredo
AU - Narvaez, Cristina
AU - Prieto, Isabel
AU - Asensio, Luis
AU - López Rojo, Irene
AU - Encinas Garcia, Sara
AU - Hurtado, Elena
AU - Jiménez, Luis M.
AU - Jiménez, Fernando
AU - Cavero, Adriana
AU - Alvaro, Edurne
AU - Fuenmayor, Maria Luisa
AU - Jiménez Toscano, Marta
AU - Iglesias Comas, Mar
AU - Balaguer, Francesc
AU - Daca, Maria
AU - Ballestero, Araceli
AU - Die Trill, Javier
AU - Sanz, Gonzalo
AU - Sanz López, Rodrigo
AU - Melone, Sirio
AU - Rueda, Jose A.
AU - Brandariz, Lorena
AU - Valverde, Ignacio
AU - Arredondo, Jorge
AU - Pastor, Carlos
AU - Garcia-Olmo, Damian
AU - Malats, Nuria
AU - Urioste, Miguel
AU - Gonzalez-Sarmiento, Rogelio
AU - Spinelli, Antonino
AU - Holowatyj, Andreana N.
N1 - Publisher Copyright:
©
PY - 2021/12/30
Y1 - 2021/12/30
N2 - Purpose The Spanish Early-onset Colorectal Cancer (SECOC) study is a multicentre prospective cohort established in Spain to investigate the molecular basis of early-onset colorectal cancer (EOCRC), including metabolic alterations. Participants 220 patients with EOCRC have been enrolled since January 2019 through 18 centres across Spain. Individual-level data were collected by questionnaire, including lifestyle and other colorectal cancer-related factors. Medical record review was performed to capture clinical, histopathological and familial cancer history data. Biospecimen collection (blood, stool, tissue) at diagnosis and at various time points across treatment, as applicable, is also completed. Findings to date Participants had a median age of 44 years (range 14-49), and the majority are men (60%), with individuals age 40-49 years at EOCRC diagnosis being over-represented. Forty-three per cent of participants were diagnosed with a tumour in the rectosigmoid junction/rectum. Nearly two-thirds of EOCRC cases (64%) were diagnosed with advanced stage (III-IV) disease, and 28% of cases had no reported familial history of cancer. Future plans We are actively recruiting and observing participants; we plan to administer follow-up questionnaires and perform additional biospecimen collection. This prospective cohort offers a unique, rich resource for research on EOCRC aetiologies and will contribute to larger international efforts to disentangle the rising disease burden.
AB - Purpose The Spanish Early-onset Colorectal Cancer (SECOC) study is a multicentre prospective cohort established in Spain to investigate the molecular basis of early-onset colorectal cancer (EOCRC), including metabolic alterations. Participants 220 patients with EOCRC have been enrolled since January 2019 through 18 centres across Spain. Individual-level data were collected by questionnaire, including lifestyle and other colorectal cancer-related factors. Medical record review was performed to capture clinical, histopathological and familial cancer history data. Biospecimen collection (blood, stool, tissue) at diagnosis and at various time points across treatment, as applicable, is also completed. Findings to date Participants had a median age of 44 years (range 14-49), and the majority are men (60%), with individuals age 40-49 years at EOCRC diagnosis being over-represented. Forty-three per cent of participants were diagnosed with a tumour in the rectosigmoid junction/rectum. Nearly two-thirds of EOCRC cases (64%) were diagnosed with advanced stage (III-IV) disease, and 28% of cases had no reported familial history of cancer. Future plans We are actively recruiting and observing participants; we plan to administer follow-up questionnaires and perform additional biospecimen collection. This prospective cohort offers a unique, rich resource for research on EOCRC aetiologies and will contribute to larger international efforts to disentangle the rising disease burden.
UR - https://www.scopus.com/pages/publications/85122622417
U2 - 10.1136/bmjopen-2021-055409
DO - 10.1136/bmjopen-2021-055409
M3 - Article
AN - SCOPUS:85122622417
SN - 2044-6055
VL - 11
JO - BMJ open
JF - BMJ open
IS - 12
M1 - e055409
ER -